[1] |
Lange C, Dheda K, Chesov D, et al. Management of drug-resistant tuberculosis. Lancet, 2019, 394(10202):953-966. doi:10.1016/S0140-6736(19)31882-3.
pmid: 31526739
|
[2] |
Tiberi S, Utjesanovic N, Galvin J, et al. Drug resistant TB-latest developments in epidemiology,diagnostics and management. Int J Infect Dis, 2022, 124:S20-S25. doi:10.1016/j.ijid.2022.03.026.
|
[3] |
Chaiyachat P, Kaewseekhao B, Chaiprasert A, et al. Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis. Sci Rep, 2023, 13(1):8655. doi:10.1038/s41598-023-35882-2.
|
[4] |
Guo H, An J, Li S, et al. Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study. J Infect Public Health, 2023, 16(8):1193-1200. doi:10.1016/j.jiph.2023.05.020.
|
[5] |
Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis, 2015, 32:87-93. doi:10.1016/j.ijid.2014.12.007.
pmid: 25809762
|
[6] |
Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol, 2017, 14(12):749-762. doi:10.1038/nrclinonc.2017.141.
pmid: 28975929
|
[7] |
国家感染性疾病临床医学研究中心, 深圳市第三人民医院,《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020, 42(4): 301-307. doi:10.3969/j.issn.1000-6621.2020.04.001.
|
[8] |
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull, 1979, 86(2):420-428. doi:10.1037/0033-2909.86.2.420.
pmid: 18839484
|
[9] |
Nogueira BMF, Krishnan S, Barreto-Duarte B, et al. Diagnostic biomarkers for active tuberculosis: progress and challenges. EMBO Mol Med, 2022, 14(12):e14088. doi:10.15252/emmm.202114088.
|
[10] |
Yip SS, Aerts HJ. Applications and limitations of radiomics. Phys Med Biol, 2016, 61(13):R150-166. doi:10.1088/0031-9155/61/13/R150.
|
[11] |
van Timmeren JE, Cester D, Tanadini-Lang S, et al. Radiomics in medical imaging- “how-to” guide and critical reflection. Insights Imaging, 2020, 11(1):91. doi:10.1186/s13244-020-00887-2.
|
[12] |
周见远, 邹思娟, 汤明, 等. 基于18F-FDG PET影像组学区分结节/肿块性肺结核与非小细胞肺癌. 放射学实践, 2021, 36(6):700-706. doi:10.13609/j.cnki.1000-0313.2021.06.002.
|
[13] |
仲艳, 王芬, 张腾, 等. 联合CT影像组学和临床影像特征在鉴别孤立性肺结节型肺隐球菌病与肺腺癌的应用价值. 影像诊断与介入放射学, 2022, 31(5):335-339. doi:10.3969/j.issn.1005-8001.2022.05.003.
|
[14] |
Li Y, Wang B, Wen L, et al. Machine learning and radiomics for the prediction of multidrug resistance in cavitary pulmonary tuberculosis: a multicentre study. Eur Radiol, 2023, 33(1):391-400. doi:10.1007/s00330-022-08997-9.
|
[15] |
Pradipta IS, Forsman LD, Bruchfeld J, et al. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. J Infect, 2018, 77(6):469-478. doi:10.1016/j.jinf.2018.10.004.
pmid: 30339803
|
[16] |
上海市感染性疾病结核病临床医学研究中心/同济大学附属上海市肺科医院, 首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所, 中国防痨协会《中国防痨杂志》编辑委员会. 复治肺结核病诊断和治疗专家共识. 中国防痨杂志, 2021, 43(12): 1226-1238. doi:10.3969/j.issn.1000-6621.2021.12.002.
|
[17] |
梁瑞云, 方伟军, 任会丽, 等. 耐药肺结核伴空洞患者的CT表现特征分析. 中国防痨杂志, 2021, 43(4):341-345. doi:10.3969/j.issn.1000-6621.2021.04.008.
|
[18] |
Im JG, Itoh H. Tree-in-Bud Pattern of Pulmonary Tuberculosis on Thin-Section CT: Pathological Implications. Korean J Radiol, 2018, 19(5):859-865. doi:10.3348/kjr.2018.19.5.859.
|